GeneDx Holdings Corp. — Form 10-Q
Filed August 3, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 28/100
What the filing says
GeneDx Holdings Corp. executed an employment agreement with Mark Gardner as President, effective on or before June 15, 2026. Gardner receives a $530,000 annual base salary, 65% performance bonus target ($344,500), and $2,000,000 in restricted stock units (RSUs) vesting over 4 years at 25% annually. The RSU grant is valued by dividing $2M by the trailing 60-day average closing stock price. Severance includes 9 months base salary (non-Change in Control) or 12 months base + 100% target bonus (Change in Control), plus 12 months COBRA premium coverage and full equity acceleration upon termination without cause during a change-of-control period.
Why this rating
Routine C-suite hire. $2.53M annual cost (~0.15% of $1.7B market cap) is immaterial. No material business event or strategic change disclosed.
See more from August 3, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.